Vimta Labs Limited has filed its quarterly regulatory certificate with stock exchanges, confirming compliance with SEBI depositories regulations for the quarter ended 31st March 2026. The certificate was submitted to both BSE Limited and National Stock Exchange of India Limited on 08th April 2026.

Regulatory Compliance Certificate

The certificate pertains to Regulation 74(5) of SEBI (Depositories & Participants) Regulations, 2018, which governs the dematerialization process of securities. The document was issued by CIL Securities Limited, serving as the company's Registrar and Transfer Agent.

Certificate Confirmation Details

CIL Securities Limited confirmed that securities received from Depository Participants for dematerialization during the quarter were properly processed and confirmed to the depositories. The certificate states that:

• Securities comprised in the certificates have been listed on stock exchanges where earlier issued securities are listed
• Security certificates received for dematerialization have been mutilated and cancelled after due verification
• Names of depositories have been substituted in the Register of Members as registered owners within the stipulated time period

Stock Exchange Filing

The certificate was filed with both major Indian stock exchanges where Vimta Labs shares are traded:

The filing was signed by Sujani Vasireddi, Company Secretary and Compliance Officer of Vimta Labs Limited, ensuring proper corporate governance and regulatory compliance for the quarter ended 31st March 2026.

Vimta Labs Limited has announced the rescheduling of its previously scheduled analyst and institutional investor meeting with Valcore Capital, along with the addition of a new meeting with CVC Partners. Both meetings are now set to take place on March 31, 2026, as part of the company's ongoing investor engagement activities under regulatory compliance requirements.

Updated Meeting Schedule

The company has provided revised details for the rescheduled meeting with Valcore Capital and announced an additional meeting with CVC Partners on the same day. Both interactions will be conducted in online mode, providing direct communication channels between the company management and institutional investors.

Rescheduling Context

The original meeting with Valcore Capital was initially scheduled for March 27, 2026, at 3:00 PM (IST). The company has now moved this meeting to March 31, 2026, with an extended duration from 3:00 PM to 4:00 PM (IST). The rescheduling was made based on mutual availability of both the management and the participants.

Regulatory Compliance

Vimta Labs has maintained its commitment to transparency while adhering to regulatory guidelines. The company has specifically stated that no unpublished price sensitive information pertaining to the company will be shared during either of the meetings with analysts and institutional investors.

The disclosure has been made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Part A of Schedule III. The company noted that the disclosure follows shorter notice provisions as permitted by SEBI circular dated February 25, 2025, with reference number SEBI/HO/CFD/CFD-PoD-2/P/CIR/2025/25 on Industry Standards.

Meeting Arrangements

The formal intimation regarding the rescheduling and additional meeting was signed by Sujani Vasireddi, Company Secretary and Compliance Officer, and submitted to both BSE Limited and National Stock Exchange of India Limited as part of the mandatory disclosure requirements. The meetings have been arranged to ensure optimal engagement while maintaining operational efficiency for all parties involved in the discussions.